Crossmark

Genetics and future therapy prospects of fibrodysplasia ossificans progressiva

Crossref DOI link: https://doi.org/10.1007/S11825-019-00279-Y

Published: 2020-01-16

Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY

Authors

Rauner, Martina

Seefried, Lothar

Shore, Eileen
License Information

unspecified valid from 2019-12-01

Text and Data Mining valid from 2019-12-01

Version of Record valid from 2020-01-16
More Information

Article History

First Online: 16 January 2020

Compliance with ethical guidelines

:

: M. Rauner, L. Seefried and E. Shore declare that they have no competing interests.

: For this article no studies with human participants or animals were performed by any of the authors. All studies performed were in accordance with the ethical standards indicated in each case.